1. Home
  2. MATW vs SLS Comparison

MATW vs SLS Comparison

Compare MATW & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Matthews International Corporation

MATW

Matthews International Corporation

HOLD

Current Price

$26.73

Market Cap

825.3M

ML Signal

HOLD

Logo SELLAS Life Sciences Group Inc.

SLS

SELLAS Life Sciences Group Inc.

HOLD

Current Price

$7.72

Market Cap

924.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MATW
SLS
Founded
1850
2012
Country
United States
United States
Employees
5500
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
825.3M
924.5M
IPO Year
1995
2007

Fundamental Metrics

Financial Performance
Metric
MATW
SLS
Price
$26.73
$7.72
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
187.6K
7.6M
Earning Date
04-30-2026
05-11-2026
Dividend Yield
3.67%
N/A
EPS Growth
59.07
50.00
EPS
0.69
N/A
Revenue
$1,795,737,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$110.98
P/E Ratio
$38.43
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.73
$1.39
52 Week High
$30.93
$9.10

Technical Indicators

Market Signals
Indicator
MATW
SLS
Relative Strength Index (RSI) 44.47 64.01
Support Level $26.48 $3.72
Resistance Level $27.41 N/A
Average True Range (ATR) 0.91 0.69
MACD -0.21 0.24
Stochastic Oscillator 13.19 67.02

Price Performance

Historical Comparison
MATW
SLS

About MATW Matthews International Corporation

Matthews International Corp is a provider of memorialization products, industrial technologies and brand solutions. The company's segments are Memorialization, Industrial Technologies and Brand Solutions. The memorialization offerings include bronze and granite memorials, caskets, and cremation-related products and equipment for cemeteries and funeral homes. Its Industrial Technologies segment designs, manufactures, services, and sells custom energy storage systems and product identification and warehouse automation solutions. The Brand Solutions segment provides brand management, pre-media, printing plates and cylinders, imaging, digital asset management, merchandising displays, and marketing and design services. The majority of revenue is generated by Memorialization.

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

Share on Social Networks: